|Articles|May 1, 2008
- Pharmaceutical Executive-05-01-2008
- Volume 0
- Issue 0
Pharm Exec 50: The Winners’ Circle
Your guide to the world's top 50 pharma companies. The giants may be struggling, but even in a tough year, the industry's most successful companies know how to hit the bullseye.
Advertisement
Articles in this issue
about 18 years ago
How Not to Handle Rebatesabout 18 years ago
Want to Be in a Health Plan? Think Like Oneabout 18 years ago
Special Report: Platform Drugs—Marketing Your Opportunitiesabout 18 years ago
Q&A with Barbara Yanniabout 18 years ago
Ready, Aim, Sellabout 18 years ago
Staying in the Gameabout 18 years ago
For the People, By the Peopleabout 18 years ago
Under Pressureabout 18 years ago
Korea's Dream Marketabout 18 years ago
Special Report: Platform Drugs—Opportunities in the Market...Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Deepening Ties: Why China is Becoming Big Pharma's Most Essential R&D Partner
2
GSK Enters $10.6 Billion Agreement to Acquire Nuvalent Inc.
3
Pharma Funding Roundup: City Therapeutics Closes $99.5 Million Series B, Eloxx Pharmaceuticals Announces Pricing of $66 Million Public Offering
4
Pharmaceutical Executive Daily: GSK Acquires Nuvalent for $10.6 Billion
5